Betulinic acid - Advanced Life Sciences
Alternative Names: ALS-357Latest Information Update: 06 May 2011
At a glance
- Originator University of Illinois at Chicago
- Developer Advanced Life Sciences
- Class Antineoplastics; Triterpenes
- Mechanism of Action Apoptosis stimulants; Caspase stimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Suspended Malignant melanoma
Most Recent Events
- 06 May 2011 Suspended - Phase-I for Malignant melanoma in USA (Topical)
- 06 May 2011 Suspended - Preclinical for Malignant melanoma in USA (PO)
- 28 Aug 2007 ALS 357 receives orphan drug status for topical treatment of metastatic melanoma in the US